Skip to content
  • ABOUT
  • SCIENCE
  • TEAM
  • NEWS
  • CONTACT US
  • Twitter
  • Linkedin

Filipe Pereira, co-founder of Asgard Therapeutics, awarded with a BII PreSeed grant

  1. Home
  2. Uncategorized
  3. Filipe Pereira, co-founder of Asgard Therapeutics, awarded with a BII PreSeed grant
  • Posted on April 1, 2020

The BioInnovation Institute (BII) awarded Filipe Pereira, co-founder of Asgard Therapeutics, with DKK 3.5M to advance pre-clinical development of dendritic cell reprogramming and define its regulatory roadmap towards the clinic.

Swedish project funded with DKK 3.5M in PreSeed program

FacebookTwitterLinkedIn
Asgard Therapeutics awarded Vinnova's Innovative Startup Step 2
Previous
Filipe Pereira, Cristiana Pires and Fábio Rosa, co-founders of Asgard Therapeutics, awarded with the Lund University and Sparbanken Skåne's prize for future innovations
Next
  • ABOUT
  • SCIENCE
  • TEAM
  • NEWS
  • CONTACT US
  • Twitter
  • Linkedin
© 2021 - ASGARD THERAPEUTICS. All rights reserved.